Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Endometrial Neoplasms × Pafolacianine × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Peritoneal Neoplasms 1 Gastrointestinal Neoplasms 1 Endometrial Neoplasms 1

Interventions

pembrolizumab 3 Tirzepatide 2 Paclitaxel 2 Metformin 2 Carboplatin 2 tislelizumab 1 olaparib 1 montelukast 1 Taxes 1 Tablets 1 Radiotherapy, Intensity-Modulated 1 Progesterone 1 Pafolacianine 1 Morphine 1 Laparotomy 1 Hysterectomy 1 Fluorescein 1 Ezetimibe 1 Biopsy 1 Atorvastatin 1 Anti-Inflammatory Agents, Non-Steroidal 1 Anesthesia, Local 1 Anesthesia, General 1 Anesthesia, Conduction 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07278986 2025-12-12

CYTALUX ISS

Abramson Cancer Center at Penn Medicine

Phase EARLY_PHASE1 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡